Hyperthyroidism secondary to kelp tablets ingestias [3]

Medicina Clinica

Volumn 118, Issue 20, 2002, Pages 797-798

  Salas Coronas, Joaquin ^a   Cruz Caparrós, Gracia ^a   Laynez Bretones, Francisco ^a   Díez García, Felipe ^a  

^a HOSPITAL DE PONIENTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALGATIN; FUCUS EXTRACT; HERBACEOUS AGENT; PROPRANOLOL; THIAMAZOLE; UNCLASSIFIED DRUG; ANTITHYROID AGENT;

ALGA; CASE REPORT; CLINICAL FEATURE; FUCUS; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; LETTER; MALE; OBESITY; PHYSICAL EXAMINATION; TABLET FORMULATION; ADULT; SEAWEED; TABLET; TIME;

ADULT; ANTITHYROID AGENTS; HUMANS; HYPERTHYROIDISM; MALE; METHIMAZOLE; SEAWEED; TABLETS; TIME FACTORS;

EID: 0036610729     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(02)72534-7     Document Type: Letter

References (8)

1. A review of iodine toxicity reports
2. The effects of amiodarone en the thyroid
3. Amiodarone iodine-induced hypothyroidism: Risk factors and follow-up in 28 cases
4. Iodine-induced hypothyroidism in patients after thyroid resection
5. Natural course of iodine-induced thyrotoxicosis (Jod Basedow) in endemic goiter area: A 5 year follow up
6. The prevention and management of iodine-induced hyperthyroidism and its cardiac features
7. Iodine-induced hyperthyroidism in a patient with a normal thyroid gland
8. Hyperthyroidism during treatment with kelp tablets